Vertex Pharmaceuticals Inc / Ma

SILVERCREST ASSET MANAGEMENT GROUP LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

16,028

Value ($000)

7,266

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	7,266	0.0%	16,028	12/31/2025
2025 Q3	11/14/2025	6,642	0.0%	16,959	9/30/2025
2025 Q2	8/14/2025	7,548	0.1%	16,953	6/30/2025
2025 Q1	5/15/2025	8,167	0.1%	16,846	3/31/2025
2024 Q4	2/14/2025	6,986	0.0%	17,348	12/31/2024
2024 Q3	11/14/2024	6,482	0.0%	13,938	9/30/2024
2024 Q2	8/15/2024	6,449	0.0%	13,759	6/30/2024
2024 Q1	5/15/2024	5,751	0.0%	13,759	3/31/2024
2023 Q4	2/14/2024	5,607	0.0%	13,779	12/31/2023
2023 Q3	11/14/2023	4,956	0.0%	14,252	9/30/2023
2023 Q2	8/14/2023	4,927	0.0%	14,002	6/30/2023
2023 Q1	5/15/2023	4,228	0.0%	13,419	3/31/2023
2022 Q4	2/14/2023	3,878	0.0%	13,429	12/31/2022
2022 Q3	11/14/2022	3,902	0.0%	13,478	9/30/2022
2022 Q2	8/15/2022	3,809	0.0%	13,518	6/30/2022
2022 Q1	5/16/2022	3,673	0.0%	14,076	3/31/2022
2021 Q4	2/14/2022	3,090	0.0%	14,070	12/31/2021
2021 Q3	11/15/2021	2,552	0.0%	14,070	9/30/2021
2021 Q2	8/16/2021	2,837	0.0%	14,070	6/30/2021
2021 Q1	5/17/2021	3,024	0.0%	14,070	3/31/2021
2020 Q4	2/16/2021	3,483	0.0%	14,736	12/31/2020
2020 Q3	11/16/2020	3,819	0.0%	14,036	9/30/2020
2020 Q2	8/14/2020	4,075	0.0%	14,036	6/30/2020
2020 Q1	5/15/2020	3,340	0.0%	14,036	3/31/2020
2019 Q4	2/14/2020	2,938	0.0%	13,417	12/31/2019
2014 Q1	5/15/2014	468	0.0%	6,614	3/31/2014
2013 Q4	2/14/2014	491	0.0%	6,614	12/31/2013